PHARMALIA: what changed
PHARMALIA
Largest movements
- Receivables within one year +€102,597
up €102,597 (+169%), from €60,864 to €163,460
of which Other amounts receivable: +€96,998
- Advances received +€120,000
new in 2025: €120,000
- Current portion of long-term debt -€62,070
down €62,070 (-90.9%), from €68,280 to €6,210
- Other debts +€60,452
up €60,452 (+843%), from €7,167 to €67,619
- Reserves +€54,849
up €54,849 (+8.4%), from €651,620 to €706,469
of which Distributable reserves: +€54,849
- Debts after one year -€40,074
down €40,074 (-92.4%), from €43,373 to €3,299
- Gross operating margin -€77,190
down €77,190 (-47.6%), from €162,122 to €84,932
- Taxes -€29,637
down €29,637 (-57.4%), from €51,609 to €21,972
- Financial income +€5,527
up €5,527, from €0 to €5,527
- Other operating charges -€2,643
down €2,643 (-67.2%), from €3,933 to €1,290
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €906,585 | €1,005,827 | +€99,242 | +10.9% |
| Fixed assets | 21/28 | €844,853 | €838,258 | -€6,595 | -0.8% |
| Tangible fixed assets | 22/27 | €19,853 | €13,258 | -€6,595 | -33.2% |
| Furniture and vehicles | 24 | €19,853 | €13,258 | -€6,595 | -33.2% |
| Financial fixed assets | 28 | €825,000 | €825,000 | = | 0.0% |
| Current assets | 29/58 | €61,732 | €167,569 | +€105,837 | +171% |
| Amounts receivable within one year | 40/41 | €60,864 | €163,460 | +€102,597 | +169% |
| Trade receivables | 40 | €8,470 | €14,068 | +€5,598 | +66.1% |
| Other amounts receivable | 41 | €52,394 | €149,392 | +€96,998 | +185% |
| Cash at bank and in hand | 54/58 | €171 | €3,355 | +€3,183 | +1,856% |
| Deferred charges and accrued income | 490/1 | €697 | €754 | +€57 | +8.2% |
| Total equity and liabilities | 10/49 | €906,585 | €1,005,827 | +€99,242 | +10.9% |
| Equity | 10/15 | €664,020 | €718,869 | +€54,849 | +8.3% |
| Contributions | 10/11 | €12,400 | €12,400 | = | 0.0% |
| Reserves | 13 | €651,620 | €706,469 | +€54,849 | +8.4% |
| Non-distributable reserves | 130/1 | €1,860 | €1,860 | = | 0.0% |
| Reserves not available under the articles | 1311 | €1,860 | €1,860 | = | 0.0% |
| Distributable reserves | 133 | €649,760 | €704,609 | +€54,849 | +8.4% |
| Amounts payable | 17/49 | €242,565 | €286,958 | +€44,393 | +18.3% |
| Amounts payable after more than one year | 17 | €43,373 | €3,299 | -€40,074 | -92.4% |
| Financial debts | 170/4 | €43,373 | €3,299 | -€40,074 | -92.4% |
| Amounts payable within one year | 42/48 | €195,802 | €279,792 | +€83,990 | +42.9% |
| Current portion of amounts payable after more than one year | 42 | €68,280 | €6,210 | -€62,070 | -90.9% |
| Financial debts | 43 | €0 | - | = | |
| Credit institutions | 430/8 | €0 | - | = | |
| Trade debts | 44 | €136 | €0 | -€136 | -100% |
| Suppliers | 440/4 | €136 | €0 | -€136 | -100% |
| Advances received on contracts in progress | 46 | - | €120,000 | +€120,000 | |
| Taxes, remuneration and social security | 45 | €120,219 | €85,963 | -€34,256 | -28.5% |
| Taxes | 450/3 | €120,219 | €85,963 | -€34,256 | -28.5% |
| Other amounts payable | 47/48 | €7,167 | €67,619 | +€60,452 | +843% |
| Accrued charges and deferred income | 492/3 | €3,389 | €3,867 | +€477 | +14.1% |
| Non-recurring operating income | 76A | €0 | - | = | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €5,122 | €6,595 | +€1,473 | +28.8% |
| Other operating charges | 640/8 | €3,933 | €1,290 | -€2,643 | -67.2% |
| Gross operating margin | 9900 | €162,122 | €84,932 | -€77,190 | -47.6% |
| Operating profit (loss) | 9901 | €153,068 | €77,048 | -€76,020 | -49.7% |
| Financial income | 75/76B | €0 | €5,527 | +€5,527 | |
| Recurring financial income | 75 | €0 | €5,527 | +€5,527 | |
| Financial charges | 65/66B | €7,156 | €5,753 | -€1,403 | -19.6% |
| Recurring financial charges | 65 | €7,156 | €5,753 | -€1,403 | -19.6% |
| Profit (loss) for the period before taxes | 9903 | €145,911 | €76,821 | -€69,090 | -47.4% |
| Income taxes | 67/77 | €51,609 | €21,972 | -€29,637 | -57.4% |
| Profit (loss) for the period | 9904 | €94,302 | €54,849 | -€39,454 | -41.8% |
| Profit (loss) for the period to be appropriated | 9905 | €94,302 | €54,849 | -€39,454 | -41.8% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 7 November 2026 via checked.be.